Cypros, Syncor International Corp. sales and marketing update

SCOR's network of 117 specialty radiopharmaceutical pharmacies will exclusively distribute unit doses of CYPR's Glofil-125, an approved injectable agent that measures renal function.

CYPR's internal sales force will continue to sell vials of Glofil for $750. Each vial can dose up to 20 patients. In cases where users require less than full vial quantities, SCOR will sell the product on a consignment basis at $125 per dose and receive a royalty. ...